ESC Premium Access

HASBLED score, frailty index or comorbidity index for bleeding risk assessment in patients with atrial fibrillation?

Presentation

About the speaker

Professor Laurent Fauchier

Tours Regional University Hospital, Hospital Trousseau, Tours (France)
12 presentations
1 follower

13 more presentations in this session

Oral anticoagulants and their effect on kidneys function, is warfarin safe?

Speaker: Associate Professor T. Novikova (Saint Petersburg, RU)

Thumbnail

Evaluation of the HAS-BLED, ATRIA and ORBIT bleeding risk scores in newly diagnosed non-valvular atrial fibrillation.

Speaker: Doctor L. Bergamaschi (Milan, IT)

Thumbnail

Inappropriate dosing of non-vitamin K oral anticoagulants (NOACs) in atrial fibrillation patients in Europe

Speaker: Ms I. Palau (London, GB)

Thumbnail

Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis

Speaker: Doctor Y. Gue (Liverpool, GB)

Thumbnail

Concomitant oral anticoagulant and antidepressant therapy in patients with atrial fibrillation and risk of stroke and bleeding: a population based cohort study

Speaker: Professor P. Hjemdahl (Stockholm, SE)

Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 1

Speakers: Professor L. Fauchier, Associate Professor T. Novikova, Doctor L. Bergamaschi, Ms I. Palau, Doctor Y. Gue...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk